- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $17.72M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $22.49M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $41.59M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $34.62M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $144.49M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $114.72M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $24.09M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $27.86M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $61.4M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $61.69M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 90.33M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $1.94M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$10.12M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $37.62M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $51.68M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.17 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.17 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $9.39M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $2.2M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$14.6M |
| Revenue | Q1 2025 · Mar 31, 2024 | $3.33M |